Janus Fund

Janus Fund is a historical growth fund with over 45 years of experience, focusing on large-cap growth investments. The firm typically participates in Series C funding rounds, leveraging its extensive expertise and in-depth fundamental research to identify promising opportunities.

Notable portfolio companies include BridgeBio Pharma, which has raised $135 million. Janus Fund's investment philosophy centers on thorough research and strategic growth, guided by key decision-makers with a deep understanding of market dynamics. The firm offers unique value-add services to support the scaling and success of its portfolio companies.